Australia markets closed

OncoZenge AB (publ) (8LY.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3155+0.0035 (+1.12%)
At close: 08:20AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 3.86M
Enterprise value 2.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.30
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.18

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-48.00%
S&P500 52-week change 326.27%
52-week high 30.6850
52-week low 30.0500
50-day moving average 30.3190
200-day moving average 30.2730

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 3N/A
Shares outstanding 511.71M
Implied shares outstanding 612.38M
Float 87.61M
% held by insiders 156.04%
% held by institutions 19.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-105,666.66%

Management effectiveness

Return on assets (ttm)-34.73%
Return on equity (ttm)-60.45%

Income statement

Revenue (ttm)3k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 7.27M
Net income avi to common (ttm)-15.9M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.63M
Total cash per share (mrq)1.08
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.94
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-17.08M
Levered free cash flow (ttm)-11.12M